These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
205 related articles for article (PubMed ID: 10216072)
1. Mast cell migratory response to interleukin-8 is mediated through interaction with chemokine receptor CXCR2/Interleukin-8RB. Nilsson G; Mikovits JA; Metcalfe DD; Taub DD Blood; 1999 May; 93(9):2791-7. PubMed ID: 10216072 [TBL] [Abstract][Full Text] [Related]
2. Expression and functional activity of the IL-8 receptor type CXCR1 and CXCR2 on human mast cells. Lippert U; Artuc M; Grützkau A; Möller A; Kenderessy-Szabo A; Schadendorf D; Norgauer J; Hartmann K; Schweitzer-Stenner R; Zuberbier T; Henz BM; Krüger-Krasagakes S J Immunol; 1998 Sep; 161(5):2600-8. PubMed ID: 9725262 [TBL] [Abstract][Full Text] [Related]
3. The CXC chemokines growth-regulated oncogene (GRO) alpha, GRObeta, GROgamma, neutrophil-activating peptide-2, and epithelial cell-derived neutrophil-activating peptide-78 are potent agonists for the type B, but not the type A, human interleukin-8 receptor. Ahuja SK; Murphy PM J Biol Chem; 1996 Aug; 271(34):20545-50. PubMed ID: 8702798 [TBL] [Abstract][Full Text] [Related]
4. Granulocyte chemotactic protein 2 acts via both IL-8 receptors, CXCR1 and CXCR2. Wolf M; Delgado MB; Jones SA; Dewald B; Clark-Lewis I; Baggiolini M Eur J Immunol; 1998 Jan; 28(1):164-70. PubMed ID: 9485196 [TBL] [Abstract][Full Text] [Related]
5. Differential usage of the CXC chemokine receptors 1 and 2 by interleukin-8, granulocyte chemotactic protein-2 and epithelial-cell-derived neutrophil attractant-78. Wuyts A; Proost P; Lenaerts JP; Ben-Baruch A; Van Damme J; Wang JM Eur J Biochem; 1998 Jul; 255(1):67-73. PubMed ID: 9692902 [TBL] [Abstract][Full Text] [Related]
6. CXC chemokines bind to unique sets of selectivity determinants that can function independently and are broadly distributed on multiple domains of human interleukin-8 receptor B. Determinants of high affinity binding and receptor activation are distinct. Ahuja SK; Lee JC; Murphy PM J Biol Chem; 1996 Jan; 271(1):225-32. PubMed ID: 8550564 [TBL] [Abstract][Full Text] [Related]
7. CXCR2 stimulation primes CXCR1 [Ca2+]i responses to IL-8 in human neutrophils. Hauser CJ; Fekete Z; Goodman ER; Kleinstein E; Livingston DH; Deitch EA Shock; 1999 Dec; 12(6):428-37. PubMed ID: 10588510 [TBL] [Abstract][Full Text] [Related]
8. Discrete steps in binding and signaling of interleukin-8 with its receptor. Wu L; Ruffing N; Shi X; Newman W; Soler D; Mackay CR; Qin S J Biol Chem; 1996 Dec; 271(49):31202-9. PubMed ID: 8940121 [TBL] [Abstract][Full Text] [Related]
9. Signalling by CXC-chemokine receptors 1 and 2 expressed in CHO cells: a comparison of calcium mobilization, inhibition of adenylyl cyclase and stimulation of GTPgammaS binding induced by IL-8 and GROalpha. Hall DA; Beresford IJ; Browning C; Giles H Br J Pharmacol; 1999 Feb; 126(3):810-8. PubMed ID: 10188995 [TBL] [Abstract][Full Text] [Related]
10. The CXC-chemokine neutrophil-activating peptide-2 induces two distinct optima of neutrophil chemotaxis by differential interaction with interleukin-8 receptors CXCR-1 and CXCR-2. Ludwig A; Petersen F; Zahn S; Götze O; Schröder JM; Flad HD; Brandt E Blood; 1997 Dec; 90(11):4588-97. PubMed ID: 9373270 [TBL] [Abstract][Full Text] [Related]
11. Expression and function of the chemokine receptors CXCR1 and CXCR2 in sepsis. Cummings CJ; Martin TR; Frevert CW; Quan JM; Wong VA; Mongovin SM; Hagen TR; Steinberg KP; Goodman RB J Immunol; 1999 Feb; 162(4):2341-6. PubMed ID: 9973513 [TBL] [Abstract][Full Text] [Related]
12. The biologic role of interleukin-8: functional analysis and expression of CXCR1 and CXCR2 on human eosinophils. Petering H; Götze O; Kimmig D; Smolarski R; Kapp A; Elsner J Blood; 1999 Jan; 93(2):694-702. PubMed ID: 9885232 [TBL] [Abstract][Full Text] [Related]
13. A His19 to Ala mutant of melanoma growth-stimulating activity is a partial antagonist of the CXCR2 receptor. Baly DL; Horuk R; Yansura DG; Simmons LC; Fairbrother WJ; Kotts C; Wirth CM; Gillece-Castro BL; Toy K; Hesselgesser J; Allison DE J Immunol; 1998 Nov; 161(9):4944-9. PubMed ID: 9794430 [TBL] [Abstract][Full Text] [Related]
14. Interruption of G protein-coupling in CXCR2 does not alter ligand binding, but eliminates ligand-activation of GTPgamma35S binding, calcium mobilization, and chemotaxis. Yang W; Schraw WP; Mueller SG; Richmond A Biochemistry; 1997 Dec; 36(49):15193-200. PubMed ID: 9398246 [TBL] [Abstract][Full Text] [Related]
15. GCP-2-induced internalization of IL-8 receptors: hierarchical relationships between GCP-2 and other ELR(+)-CXC chemokines and mechanisms regulating CXCR2 internalization and recycling. Feniger-Barish R; Belkin D; Zaslaver A; Gal S; Dori M; Ran M; Ben-Baruch A Blood; 2000 Mar; 95(5):1551-9. PubMed ID: 10688807 [TBL] [Abstract][Full Text] [Related]
16. Regulation of the expression of IL-8 receptor A/B by IL-8: possible functions of each receptor. Chuntharapai A; Kim KJ J Immunol; 1995 Sep; 155(5):2587-94. PubMed ID: 7650389 [TBL] [Abstract][Full Text] [Related]
17. Neutrophil gelatinase B potentiates interleukin-8 tenfold by aminoterminal processing, whereas it degrades CTAP-III, PF-4, and GRO-alpha and leaves RANTES and MCP-2 intact. Van den Steen PE; Proost P; Wuyts A; Van Damme J; Opdenakker G Blood; 2000 Oct; 96(8):2673-81. PubMed ID: 11023497 [TBL] [Abstract][Full Text] [Related]
18. The interleukin-8 receptor B and CXC chemokines can mediate transendothelial migration of human skin homing T cells. Santamaria Babi LF; Moser B; Perez Soler MT; Moser R; Loetscher P; Villiger B; Blaser K; Hauser C Eur J Immunol; 1996 Sep; 26(9):2056-61. PubMed ID: 8814246 [TBL] [Abstract][Full Text] [Related]
19. Neutrophils regulate their own apoptosis via preservation of CXC receptors. Dunican A; Grutkoski P; Leuenroth S; Ayala A; Simms HH J Surg Res; 2000 May; 90(1):32-8. PubMed ID: 10781372 [TBL] [Abstract][Full Text] [Related]
20. Overexpression of CXC-chemokines and CXC-chemokine receptor type II constitute an autocrine growth mechanism in the epidermoid carcinoma cells KB and A431. Metzner B; Hofmann C; Heinemann C; Zimpfer U; Schraufstätter I; Schöpf E; Norgauer J Oncol Rep; 1999; 6(6):1405-10. PubMed ID: 10523720 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]